Analyzing Mobilicom (NASDAQ:MOB) and Halma (OTCMKTS:HLMAF)

Mobilicom (NASDAQ:MOB) and Halma (OTCMKTS:HLMAF) are both industrials companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability.

Analyst Ratings

This is a summary of recent ratings for Mobilicom and Halma, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobilicom	1	1	2	0	2.25
Halma	1	2	2	2	2.71

Mobilicom currently has a consensus price target of $2,750.00, indicating a potential upside of 38,147.57%. Given Mobilicom’s higher possible upside, analysts clearly believe Mobilicom is more favorable than Halma.

Risk & Volatility

Mobilicom has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Comparatively, Halma has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500.

Valuation & Earnings

This table compares Mobilicom and Halma”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobilicom	$3.36 million	26.13	-$23.73 million	N/A	N/A
Halma	$2.87 billion	8.34	$378.18 million	N/A	N/A

Halma has higher revenue and earnings than Mobilicom.

Institutional and Insider Ownership

13.6% of Mobilicom shares are owned by institutional investors. 7.2% of Mobilicom shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Mobilicom and Halma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mobilicom	N/A	N/A	N/A
Halma	N/A	N/A	N/A

Summary

Mobilicom beats Halma on 5 of the 9 factors compared between the two stocks.

About Mobilicom

Mobilicom Limited operates as an end-to-end provider of cybersecurity and smart solutions for drones, robotics, and autonomous platforms. It designs, develops, and delivers smart solutions, such as cloud management software, communication datalink and mobile mesh networking terminals, handheld control terminals, and professional services and support for drone, robotics, and autonomous system manufacturers, as well as hardware products and software solutions. Mobilicom Limited was incorporated in 2017 and is based in Shoham, Israel.

About Halma

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire safety, fire detection and fire suppression; safe movement in public, commercial, and industrial spaces; elevator safety; communications in emergencies; control of access in potentially hazardous industrial and commercial environments; electrical safety; and the safe management of pipelines and storage assets solutions. This segment serves shops and restaurants, healthcare facilities, and offices and stadiums; industrial and logistics assets; public spaces and critical infrastructure; and aerospace, and rail and automotive markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring, water and waste water analysis and treatment, gas analysis and detection, and optical analysis systems. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; components, devices and systems that provide information and analytics to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.